Page last updated: 2024-11-04

sotalol and Disease Exacerbation

sotalol has been researched along with Disease Exacerbation in 3 studies

Sotalol: An adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias.
sotalol : A sulfonamide that is N-phenylmethanesulfonamide in which the phenyl group is substituted at position 4 by a 1-hydroxy-2-(isopropylamino)ethyl group. It has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties. It is used (usually as the hydrochloride salt) for the management of ventricular and supraventricular arrhythmias.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Huang, KY1
Tseng, PT1
Wu, YC1
Tu, YK1
Stubbs, B1
Su, KP1
Matsuoka, YJ1
Hsu, CW1
Lin, CH1
Chen, YW1
Lin, PY1
Kobayashi, M1
Kwak, MJ1
Aguilar, D1
Goyal, P1
Holmes, HM1
Deshmukh, AA1
Aparasu, RR1
Venkataraman, G1
Strickberger, SA1

Reviews

1 review available for sotalol and Disease Exacerbation

ArticleYear
Do beta-adrenergic blocking agents increase asthma exacerbation? A network meta-analysis of randomized controlled trials.
    Scientific reports, 2021, 01-11, Volume: 11, Issue:1

    Topics: Administration, Oral; Adrenergic beta-Antagonists; Atenolol; Bisoprolol; Cardiovascular Diseases; Ce

2021

Other Studies

2 other studies available for sotalol and Disease Exacerbation

ArticleYear
Prescribing Trend of Inappropriate Medications in Outpatient Clinics for Older Adults With Heart Failure in the United States: NAMCS 2012 to 2016.
    The American journal of cardiology, 2021, 08-01, Volume: 152

    Topics: Aged; Ambulatory Care; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Antidepressi

2021
Atrial fibrillation degenerates into ventricular fibrillation.
    Journal of the American College of Cardiology, 2010, Mar-09, Volume: 55, Issue:10

    Topics: Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Combined Modality Therapy; Defibrillators, Impla

2010